著者

平賀 秀明 草野 真雪子 山﨑 彩菜子 緒方 美咲 植草 秀介 菅澤 彩香 多賀谷 理央 秋本 義雄 眞鍋 知史 木内 規之 大橋 綾子 早田 佳奈 久山 登

出版者

日本社会薬学会

雑誌

社会薬学 (ISSN:09110585)

巻号頁・発行日

vol.41, no.1, pp.10-27, 2022-06-10 (Released:2022-06-21)

参考文献数

22

---

Owing to the fear of worsening their relationship with physicians, several pharmacists hesitate to contact physicians regarding prescription-related questions. We investigated the personal factors of pharmacists contributing to their hesitation to contact physicians regarding prescription-related questions. We analyzed the responses of 213 pharmacy pharmacists. A comparison of the degree of hesitation to contact physicians regarding prescription-related questions revealed that the most hesitant questions were pertaining to “the same prescription content from before”; insurance questions (3.37) were higher than medical questions (3.20) (P=0.006). The multiple regression analysis results revealed that “pharmacy work is busy and there is no time” was influenced by regular employees (medical (β=−0.181, P=0.030) and insurance (β=−0.257, P=0.002)). “A co-pharmacist said no questions needed” was influenced by the sex of pharmacists (medical (β=0.194, P=0.011) and insurance (β=0.177, P=0.020)). Overall, type of questions (medical or insurance) and individual backgrounds (prescription issuing medical institution, pharmacy scale, location, age, sex, employment type, years of service, current management pharmacist, and hospital work experience) have a complex effect on the pharmacists’ psychology. To facilitate pharmacists to contact physicians regarding prescription-related questions, physicians and pharmacists should share information and communicate on a daily basis, such as actively participate in joint training programs. It is also important to create an environment where regular employees and female pharmacists can work comfortably. The smooth resolution of prescription-related questions by relieving the psychological pressure of pharmacists will improve patient safety.

著者

吉田 栄子 大川原 美紀 劉 亦韋 矢野 裕一 喩 静 川崎 力 秋本 義雄 平賀 秀明

出版者

日本社会薬学会

雑誌

社会薬学 (ISSN:09110585)

巻号頁・発行日

vol.39, no.2, pp.79-86, 2020-12-10 (Released:2020-12-30)

参考文献数

28

---

China’s pharmaceutical market, the second largest in the world, has recently attracted the attention of many countries. However, Chinese pharmacists’ role in pharmacies and their legal responsibilities in China are not well known in Japan. Clarifying Chinese pharmacists’ legal obligations and identifying their specific roles may contribute to improvements in pharmacy operations in Japan. To investigate the Chinese legal system as it pertains to pharmacists in China, we used China’s official government website. In 2019, there were 516,003 pharmacists in China. As of 2020, the Chinese Pharmacist Act is still in the preparatory stage; however, the Administrative Regulation, which describes the system for licensing pharmacists, has been established. Article 1 of the Administrative Regulation states that Chinese pharmacists are responsible for the quality control of medications, as well as medication consultations. Another regulation, Good Supply Practice, specifies that the lot numbers of medications should be provided to patients at the time of dispensing. We believe that this is particularly beneficial to pharmaceutical traceability. Since 2017, the circulation of counterfeit HARVONI® combination tablets has been a problem in Japan. To secure and improve the quality of medications in Japan, we believe that it is important for pharmacists to understand that they are “responsible for the quality of the medicine” and to promote discussions on pharmacy quality control tasks.